Molecular mechanisms regulating the growth and differentiation of hematopoietic stem cells

调节造血干细胞生长和分化的分子机制

基本信息

  • 批准号:
    12470200
  • 负责人:
  • 金额:
    $ 8.83万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

(1) Stem cell factor (SCF) has crucial roles in proliferation, survival and differentiation of hematopoietic stem cells through binding to c-Kit receptor (KIT). We made a series of 22 KIT mutants, in which Tyr (Y) residue was substituted to Phe (F) in the cytoplasmic domain, and introduced into BAF3 cells. On stimulation with SCF, BAF3 expressing KIT^<WT>(WT) showed cell migration and Ca^<2+> mobilization. Among 22YF mutants, Y567F and Y719F showed significantly reduced cell migration and Ca^<2+> mobilization. Analysis on signaling cascades suggested that Y567-mediated Src family kinase (SFK) activation led to Ca^<2+> influx and migration, and that P38MAPkinase (P38MAPK) and Erk1/2 were also regulated by Y567/SFK and involved in cell migration. Also, Y719-mediated PI3K pathway was suggested to be involved in the migration. These results indicate that two major KIT signaling pathways lead to cell migration, one is Y567-SFK-p38MAPK-Erk and another is Y719-PI3 kinase.(2) Thrombopoietin (T … More PO) and its receptor c-mpl play crucial roles in growth and megakaryocytic differentiation of hematopoietic stem cells. We found that Ras activation was involved in thrombopoietin (TPO)-induced megakaryocytic differentiation. Furthermore, we demonstrated that GATA-1 activities was required for the Ras-mediated megakaryocytic differentiation, and that GATA-1 activities were regulated negatively by the direct interaction with other lineage-specific transcription factors, PU.1 and c-Myb.(3) AIM-1 belongs to an Aurora/Ipl1 serine threonine kinase family, and is supposed to play key roles in mitosis. In human hematopoietic cells, expression of AIM-1 was restrictedly observed at G2/M phase of cell cycle. In contrast, AIM-1 was continuously repressed during megakaryocytic polyploidization. Supplement of AIM-1 activities by the induced expression of wild-type AIM-1 canceled TPA-induced polyploidization of K562 cells, and the suppression of AIM-1 activities by dominant-negative AIM-1 led to polyploidization. These results suggested that down-regulation of AIM-1 at M phase may be involved in abortive mitosis and polyploid formation of megakaryocytes. Less
(1)干细胞因子(SCF)通过与C-KIT接收器(KIT)的结合在造血干细胞的增殖,存活和分化中具有至关重要的作用。我们制作了一系列22个试剂盒突变体,其中Tyr(Y)居住在细胞质结构域中的PHE(F),并引入BAF3细胞中。在用SCF刺激时,表达Kit^<wt>(WT)的BAF3显示了细胞迁移和Ca^<2+>动员。在22年突变体中,Y567F和Y719F显示出细胞迁移和动员的细胞迁移显着降低。对信号级联的分析表明,Y567介导的SRC家族激酶(SFK)激活导致CA^<2+>影响和迁移,并且p38mapkinase(p38mapk)和ERK1/2也受到Y567/SFK的调节,并参与细胞迁移。另外,建议Y719介导的PI3K途径参与迁移。这些结果表明,两种主要的套件信号通路导致细胞迁移,一个是Y567-SFK-P38MAPK-ERK,另一个是Y719-PI3激酶。(2)血栓植物(T…更多PO)及其接收器C-MPL在生长和巨核细胞中的血液中起着至关重要的作用。我们发现RAS激活参与血小板蛋白(TPO)引起的巨核细胞分化。此外,我们证明了RAS介导的巨核细胞分化需要GATA-1活性,并且与与其他特定谱系特异性转录因子PU.1和C-MYB的直接相互作用(3)AIM-1属于AURORA/IPL1柔软的Terreon kinase Kiners,以及对MIT的键入,对GATA-1的活性受到负面调节。在人造血细胞中,在细胞周期的G2/m期有限观察到AIM-1的表达。相反,在巨核细胞多倍化过程中,AIM-1连续反射。通过诱导的野生型AIM-1的表达来补充AIM-1活性,取消了TPA诱导的K562细胞的多倍体化,以及通过显性阴性的AIM-1抑制AIM-1活性导致多倍体化。这些结果表明,在M期的AIM-1下调可能与巨核细胞的流产有丝分裂和多倍体形成有关。较少的

项目成果

期刊论文数量(58)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kawasaki, A., Matsumura, I., Miyagawa, J., Ezoe, S., Tanaka, H., Terada, Y., Tatsuka, M., Machii, T., Miyazaki, H., Furukawa, Y., and Kanakura, Y.: "Down-regulation of and AIM-1 kinase couples with megakaryocytic polyploidization of human hematopoietic ce
川崎,A.,松村,I.,宫川,​​J.,Ezoe,S.,田中,H.,寺田,Y.,龙香,M.,町井,T.,宫崎,H.,古川,Y.,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nishimura, J-I., Philips, K.L., Ware, R.E., Hall, S., Wilson, L., Gentry, T.L., Howard, T.A.., Murakami, Y., Shibano, M., Machii, T., Gilboa, E., Kanakura, Y., Takeda, J., Kinoshita, T., Rosse, W.F., and Smith, C.A.: "Efficient retrovirus-mediated PIG-A g
Nishimura, J-I.、Philips, K.L.、Ware, R.E.、Hall, S.、Wilson, L.、Gentry, T.L.、Howard, T.A.、Murakami, Y.、Shibano, M.、Machii, T.、Gilboa, E
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Ueda, S., et al.: "Critical roles of c-kit tyrosine residues 567 and 719 in stem cell factor-induced chemotaxis"Blood. (in press).
Ueda, S., et al.:“c-kit 酪氨酸残基 567 和 719 在干细胞因子诱导的趋化性中的关键作用”血液。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Matsumura, I., Hashimoto, K, Ikeda, H., Odajima, J., Tanaka, H., Kato, T, Miyazaki, H., and Kanakura, Y.: "Increased D-type cyclin expression together with decreased cdc2 activity confers megakaryocytic differentiation of a human thrombopoietin-dependent
Matsumura, I.、Hashimoto, K、Ikeda, H.、Odajima, J.、Tanaka, H.、Kato, T、Miyazaki, H. 和 Kanakura, Y.:“D 型细胞周期蛋白表达增加,同时 cdc2 减少
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Sonoyama, J., et al.: "Functional cooperation among Ras, STAT5, and P13-K is required for full oncogenic activitics of BCR/ABL in K562 cells"J. Biol. Chem.. (in press).
Sonoyama, J. 等人:“K562 细胞中 BCR/ABL 的完全致癌活性需要 Ras、STAT5 和 P13-K 之间的功能合作”。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KANAKURA Yuzuru其他文献

KANAKURA Yuzuru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KANAKURA Yuzuru', 18)}}的其他基金

Functional analysis of SATB1, a global transcription regulator, in hematopoietic stem cells
造血干细胞中全局转录调节因子 SATB1 的功能分析
  • 批准号:
    16H05339
  • 财政年份:
    2016
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of the functions of anti-apoptotic molecule, Anamorsin -the roles in hematopoiesis and cellular iron metabolism-
抗凋亡分子Anamorsin的功能分析-在造血和细胞铁代谢中的作用-
  • 批准号:
    25293220
  • 财政年份:
    2013
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Screening of low molecular compounds, which inhibit cell proliferation and survival
筛选抑制细胞增殖和存活的低分子化合物
  • 批准号:
    23659488
  • 财政年份:
    2011
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Analysis of functions of anamorsin, an anti-apoptotic molecule, in hematopoiesis
抗凋亡分子阿莫辛的造血功能分析
  • 批准号:
    22390194
  • 财政年份:
    2010
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Synthetic Analysis on the mechanisms of survival and differentiation of hematopoietic cells
造血细胞存活和分化机制的综合分析
  • 批准号:
    18209034
  • 财政年份:
    2006
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Analysis of molecular mechanisms of leukemia
白血病分子机制分析
  • 批准号:
    17016042
  • 财政年份:
    2005
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Analysis on the mechanisms of growth, differentiation, and survival of megakaryocytic cells
巨核细胞生长、分化和存活机制分析
  • 批准号:
    16209033
  • 财政年份:
    2004
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Analysis on the mechanism of survival, growth and differentiation of hematopoietic cells
造血细胞存活、生长和分化机制分析
  • 批准号:
    14370302
  • 财政年份:
    2002
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Receptor-mediated signalings-regulating proliferation, differentiation and neoplastic transformation of hematopoietic cells
受体介导的信号传导——调节造血细胞的增殖、分化和肿瘤转化
  • 批准号:
    09470231
  • 财政年份:
    1997
  • 资助金额:
    $ 8.83万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似国自然基金

牛前体脂肪细胞增殖分化过程中可翻译circRNAs鉴定及其功能与调控机制研究
  • 批准号:
    32372852
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
巨噬/小胶质细胞的MyD88信号诱导脊髓损伤后室管膜细胞增殖分化的研究
  • 批准号:
    82301552
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
调控小鼠造血干祖细胞增殖与分化的RNA结合蛋白筛选及机制研究
  • 批准号:
    32300667
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
利用SynNotch技术探究造血微环境调控造血干祖细胞增殖与分化的分子机制
  • 批准号:
    32300696
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
FCER1G对Ph-骨髓增殖性肿瘤CD4+T细胞分化的免疫调控及机制研究
  • 批准号:
    82360029
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
阐明神经纤维瘤病的表观遗传景观和治疗靶点的开发
  • 批准号:
    10473771
  • 财政年份:
    2021
  • 资助金额:
    $ 8.83万
  • 项目类别:
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
阐明神经纤维瘤病的表观遗传景观和治疗靶点的开发
  • 批准号:
    10680527
  • 财政年份:
    2021
  • 资助金额:
    $ 8.83万
  • 项目类别:
Elucidating the epigenetic landscape of neurofibromatosis and development of therapeutic targets
阐明神经纤维瘤病的表观遗传景观和治疗靶点的开发
  • 批准号:
    10211400
  • 财政年份:
    2021
  • 资助金额:
    $ 8.83万
  • 项目类别:
Computational Models of the Human Cell Cycle to Reveal Disease Mechanism and Inform Treatment
人类细胞周期的计算模型揭示疾病机制并为治疗提供信息
  • 批准号:
    10033514
  • 财政年份:
    2020
  • 资助金额:
    $ 8.83万
  • 项目类别:
Computational Models of the Human Cell Cycle to Reveal Disease Mechanism and Inform Treatment
人类细胞周期的计算模型揭示疾病机制并为治疗提供信息
  • 批准号:
    10261500
  • 财政年份:
    2020
  • 资助金额:
    $ 8.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了